The British pharmaceutical company GlaxoSmithKline recently announced that, together with the US National Institute of Allergy and Infectious Diseases, it is developing an experimental vaccine for Ebola. But it is just entering phase I clinical trials to test toxicity.
英国制药公司葛兰素史克最近宣布正和美国国家过敏和传染病学院一道开展埃博拉疫苗的试验工作。但试验工作还仅仅处在毒理测试临床试验I期。因为还要完成两个阶段的试验，疫苗不会在2015年之前面世。